InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BioAge Labs, Inc.

BIOA Clue Score39
United States Fiscal year ends December CIK 0001709941 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Vijay Satyanand Pande
3 Oct 2024
Director
Buy indirect
25,306
$19.90
$503.59K
Vijay Satyanand Pande
2 Oct 2024
Director
Buy indirect
67,096
$19.73
$1.32M
Vijay Satyanand Pande
1 Oct 2024
Director
Buy indirect
126,793
$19.73
$2.50M
James Healy
27 Sep 2024
Director
Buy indirect
26,497
$18.00
$476.95K
James Healy
27 Sep 2024
Director
Buy indirect
21,814
$18.00
$392.65K
James Healy
27 Sep 2024
Director
Buy indirect
18,353
$18.00
$330.35K
James Healy
27 Sep 2024
Director
Buy indirect
11,113
$18.00
$200.03K
James Healy
27 Sep 2024
Director
Buy indirect
588,888
$18.00
$10.60M
Patrick G Enright
27 Sep 2024
Director
Buy indirect
400,000
$18.00
$7.20M
Vijay Satyanand Pande
27 Sep 2024
Director
Buy indirect
900,000
$18.00
$16.20M
Cormorant Asset Management, LP
27 Sep 2024
Former 10% Owner
Buy indirect
450,000
$18.00
$8.10M
Shane Barton
27 Sep 2024
Principal Accounting Officer
Buy
2,632
$18.00
$47.38K
Show all 29 transactions →

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 6,461,446
History held since 27 Sep 2024